1. Market Research
  2. > Business Services
  3. > Business Process Outsourcing Market Trends
Asia Pacific Small Molecule Drug Discovery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapeutic Area ; Process/Phase, and Country

Asia Pacific Small Molecule Drug Discovery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapeutic Area ; Process/Phase, and Country

  • August 2020
  • 119 pages
  • ID: 5974340
  • Format: PDF
  • The Insight Partners
Up to $1000 off Until Nov 30th 2020


Table of Contents

Search Inside

Asia Pacific Small Molecule Drug Discovery Market to 2027 – COVID-19 Impact Analysis and Forecast – by Therapeutic Area and Process/Phase
The Asia Pacific small molecule drug discovery market is expected to reach US$ 8,797.47 million by 2027 from US$ 4,146.40 million in 2019. The market is estimated to grow at a CAGR of 10.1% from 2020 to 2027. The Asia Pacific small molecule drug discovery market is growing primarily due to increasing approval of small molecule drugs, growing demand for R&D from contract organizations, and rising adoption of small molecules in chronic disease treatments in the region. Additionally, growing adoption of artificial intelligence (AI) in drug discovery and increasing small molecule-based pipeline are likely to fuel the growth of the small molecule drug discovery market during the forecast period. However, factors such as high cost of drug development may hamper the growth of the market.
Small molecule drugs are used in targeted drug delivery in which small molecules pass through the cell membrane and act on the specific cellular organelle or protein.The small molecule drugs are able to enter cells easily because of their low molecular weight.

These molecules are better than monoclonal antibodies and other large molecule drugs as they are smaller in size, easy to convert into oral form, and highly cost-effective.The discovery of novel small molecule entities that are capable of specific interactions represents a significant challenge in the early stages of drug discovery.

When the biological target is well defined and understood, the rational design of small molecule ligands is possible. In the recent years, the small molecule drugs have witnessed significant attention over biologics, as an increase in demand for these drugs has been observed.
Artificial intelligence and associated technologies are making drug discovery cost-effective and quick.Leading biopharmaceutical companies have been utilizing AI platforms to accelerate the drug discovery of novel therapeutics.

Currently, AI tools are used in screening and identifying compounds. They are also used to minimize drug interactions that may cause issues later.
With the rapid introduction of AI in healthcare, numerous pharmaceutical companies have made investments in joint ventures with AI companies to develop better healthcare tools.These include identification of drug targets and designing new drugs.

Therefore, numerous partnerships between pharmaceutical industries and AI companies and government organizations were witnessed.Moreover, growing number of AI start-ups in drug discovery technologies is further accelerating the growth of the market.

In the field of mental health, this type of efficient drug discovery offers increased effectiveness of the treatment.
Considering the geographic and economic operations between Asian countries and China, the countries are anticipated to witness challenge of COVID-19 pandemic.This pandemic may also cause both medium- and longer-term negative impacts on R&D and manufacturing activities and delay on projects.

Moreover, a large number of contract research organizations are based in Asia Pacific, especially in China.The COVID-19 outbreak has forced many CROs to close their manufacturing and development plants to avoid the increase in cases.

These factors are affecting the growth of the small molecule drug discovery market in the region.
In terms of therapeutic area, the oncology segment accounted for the highest share of the market in 2019.This can be attributed to increasing need for better understanding of the disease and development of effective therapies to combat rising prevalence of the disease.

Furthermore, untapped opportunities in cancer treatment to discover targets that can yield into a viable drug compound engage market players to conduct research in these areas. The dominance of the oncology segment is further attributed to huge investments made by the biopharmaceutical companies in identifying new small molecules of cancer and inclination toward immune-oncology therapies.
A few major secondary sources associated with the Asia Pacific small molecule drug discovery market report include World Health Organization (WHO) and Centre for the Study of Drug Development (CSDD).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on